HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Clinical trials for HORMONE-RECEPTOR-POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-RECEPTOR-POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HORMONE-RECEPTOR-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for Tough-to-Treat breast cancer
Disease control CompletedThis early-phase study tested a combination of the oral chemotherapy capecitabine and the immunotherapy drug cemiplimab in 13 people with hormone receptor-positive breast cancer that had spread. The goal was to find the safest dose and see if the combo could shrink tumors. While …
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 16, 2026 23:52 UTC
-
New hope in hormone therapy battle against advanced breast cancer
Disease control CompletedThis study tested two hormone-blocking drugs, fulvestrant and anastrozole, in 462 postmenopausal women with advanced breast cancer that is fueled by hormones. The goal was to see which drug better delays cancer growth. Participants had not received hormone therapy before. The res…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Real-World study reveals patient experience on hormone therapy for breast cancer
Knowledge-focused CompletedThis study followed 562 premenopausal women in China with hormone receptor-positive breast cancer who received a GnRHa injection to suppress ovarian function after surgery. Researchers measured quality of life and how well patients followed their treatment plan using questionnair…
Matched conditions: HORMONE-RECEPTOR-POSITIVE BREAST CANCER
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated May 16, 2026 23:48 UTC